

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ribosomal small subunit assembly (GO:0000028) | 7.14133495 |
| 2 | DNA deamination (GO:0045006) | 6.47179635 |
| 3 | viral transcription (GO:0019083) | 5.82789910 |
| 4 | translational termination (GO:0006415) | 5.60570323 |
| 5 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 5.01612352 |
| 6 | translational elongation (GO:0006414) | 5.00465564 |
| 7 | ribosomal small subunit biogenesis (GO:0042274) | 4.93944018 |
| 8 | cotranslational protein targeting to membrane (GO:0006613) | 4.89658922 |
| 9 | protein targeting to ER (GO:0045047) | 4.87022525 |
| 10 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.66943426 |
| 11 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.66943426 |
| 12 | protein localization to endoplasmic reticulum (GO:0070972) | 4.64440995 |
| 13 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 4.63383730 |
| 14 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.59460656 |
| 15 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.54788237 |
| 16 | maturation of SSU-rRNA (GO:0030490) | 4.54432255 |
| 17 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 4.40758422 |
| 18 | DNA strand elongation (GO:0022616) | 4.36944616 |
| 19 | viral life cycle (GO:0019058) | 4.34058018 |
| 20 | antigen processing and presentation via MHC class Ib (GO:0002475) | 4.32058021 |
| 21 | neutrophil activation involved in immune response (GO:0002283) | 4.26145268 |
| 22 | cellular protein complex disassembly (GO:0043624) | 4.24804444 |
| 23 | translational initiation (GO:0006413) | 4.21695854 |
| 24 | response to peptidoglycan (GO:0032494) | 3.97144844 |
| 25 | telomere maintenance via recombination (GO:0000722) | 3.87517066 |
| 26 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.85456047 |
| 27 | protein complex disassembly (GO:0043241) | 3.83002916 |
| 28 | DNA replication initiation (GO:0006270) | 3.78708382 |
| 29 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.76869705 |
| 30 | DNA unwinding involved in DNA replication (GO:0006268) | 3.68997530 |
| 31 | macromolecular complex disassembly (GO:0032984) | 3.60257341 |
| 32 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.59169564 |
| 33 | negative regulation of cell killing (GO:0031342) | 3.59169564 |
| 34 | positive regulation of B cell differentiation (GO:0045579) | 3.56887095 |
| 35 | platelet dense granule organization (GO:0060155) | 3.51864928 |
| 36 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.50909696 |
| 37 | mitotic recombination (GO:0006312) | 3.48038635 |
| 38 | detection of bacterium (GO:0016045) | 3.45971804 |
| 39 | detection of other organism (GO:0098543) | 3.42347328 |
| 40 | pseudouridine synthesis (GO:0001522) | 3.42318239 |
| 41 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.42177710 |
| 42 | negative regulation of interleukin-12 production (GO:0032695) | 3.40887777 |
| 43 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.40581839 |
| 44 | ribosomal large subunit biogenesis (GO:0042273) | 3.39802178 |
| 45 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.38101752 |
| 46 | telomere maintenance via telomere lengthening (GO:0010833) | 3.36871658 |
| 47 | formation of translation preinitiation complex (GO:0001731) | 3.31996089 |
| 48 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.28700476 |
| 49 | tolerance induction (GO:0002507) | 3.28144078 |
| 50 | mRNA catabolic process (GO:0006402) | 3.27498516 |
| 51 | lymphoid progenitor cell differentiation (GO:0002320) | 3.27406218 |
| 52 | negative regulation of phagocytosis (GO:0050765) | 3.25204248 |
| 53 | definitive hemopoiesis (GO:0060216) | 3.23554649 |
| 54 | protein targeting to membrane (GO:0006612) | 3.22318403 |
| 55 | positive regulation by symbiont of host defense response (GO:0052509) | 3.20414343 |
| 56 | modulation by symbiont of host defense response (GO:0052031) | 3.20414343 |
| 57 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.20414343 |
| 58 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.20414343 |
| 59 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.20414343 |
| 60 | modulation by symbiont of host immune response (GO:0052553) | 3.20414343 |
| 61 | translation (GO:0006412) | 3.19929709 |
| 62 | response to interferon-beta (GO:0035456) | 3.19679331 |
| 63 | positive regulation of antigen processing and presentation (GO:0002579) | 3.16752550 |
| 64 | RNA catabolic process (GO:0006401) | 3.14487035 |
| 65 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.10020596 |
| 66 | neutrophil activation (GO:0042119) | 3.07840887 |
| 67 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.07725107 |
| 68 | positive thymic T cell selection (GO:0045059) | 3.06175591 |
| 69 | positive regulation of mast cell activation (GO:0033005) | 3.03877847 |
| 70 | nucleobase biosynthetic process (GO:0046112) | 3.02262093 |
| 71 | positive regulation of mast cell degranulation (GO:0043306) | 3.02228528 |
| 72 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.02228528 |
| 73 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.00324411 |
| 74 | regulation of T cell tolerance induction (GO:0002664) | 2.99246217 |
| 75 | negative regulation of B cell apoptotic process (GO:0002903) | 2.96751078 |
| 76 | leukocyte aggregation (GO:0070486) | 2.94639368 |
| 77 | respiratory burst (GO:0045730) | 2.94541211 |
| 78 | regulation of antigen processing and presentation (GO:0002577) | 2.94430291 |
| 79 | myeloid cell activation involved in immune response (GO:0002275) | 2.92583679 |
| 80 | granulocyte activation (GO:0036230) | 2.91181820 |
| 81 | cellular extravasation (GO:0045123) | 2.89396203 |
| 82 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.87524707 |
| 83 | rRNA processing (GO:0006364) | 2.86620639 |
| 84 | regulation of mast cell degranulation (GO:0043304) | 2.85861523 |
| 85 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.85712750 |
| 86 | leukocyte degranulation (GO:0043299) | 2.85156475 |
| 87 | regulation of tolerance induction (GO:0002643) | 2.84506012 |
| 88 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.82625483 |
| 89 | mature B cell differentiation involved in immune response (GO:0002313) | 2.82540725 |
| 90 | pentose-phosphate shunt (GO:0006098) | 2.80942189 |
| 91 | negative thymic T cell selection (GO:0045060) | 2.80793693 |
| 92 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.80707447 |
| 93 | negative T cell selection (GO:0043383) | 2.80182742 |
| 94 | negative regulation of RNA splicing (GO:0033119) | 2.75376112 |
| 95 | rRNA metabolic process (GO:0016072) | 2.75073160 |
| 96 | IMP metabolic process (GO:0046040) | 2.74609507 |
| 97 | pinocytosis (GO:0006907) | 2.74298758 |
| 98 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.73573763 |
| 99 | purine-containing compound salvage (GO:0043101) | 2.73447652 |
| 100 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.73278547 |
| 101 | regulation of gamma-delta T cell activation (GO:0046643) | 2.72342340 |
| 102 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.71898277 |
| 103 | immunoglobulin mediated immune response (GO:0016064) | 2.71424172 |
| 104 | purine nucleobase biosynthetic process (GO:0009113) | 2.69138386 |
| 105 | regulation of B cell apoptotic process (GO:0002902) | 2.68666922 |
| 106 | detection of external biotic stimulus (GO:0098581) | 2.68558336 |
| 107 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.67954719 |
| 108 | endosome to pigment granule transport (GO:0043485) | 2.67930863 |
| 109 | endosome to melanosome transport (GO:0035646) | 2.67930863 |
| 110 | regulation of B cell differentiation (GO:0045577) | 2.66825927 |
| 111 | defense response to protozoan (GO:0042832) | 2.66360896 |
| 112 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.65829384 |
| 113 | ribosome biogenesis (GO:0042254) | 2.63967631 |
| 114 | autophagic vacuole fusion (GO:0000046) | 2.63578896 |
| 115 | mast cell activation (GO:0045576) | 2.63337910 |
| 116 | deoxyribonucleotide catabolic process (GO:0009264) | 2.62453468 |
| 117 | cellular response to type I interferon (GO:0071357) | 2.62374125 |
| 118 | type I interferon signaling pathway (GO:0060337) | 2.62374125 |
| 119 | DNA replication checkpoint (GO:0000076) | 2.61304516 |
| 120 | regulation of mast cell activation (GO:0033003) | 2.60850053 |
| 121 | response to protozoan (GO:0001562) | 2.60368825 |
| 122 | CENP-A containing nucleosome assembly (GO:0034080) | 2.59562130 |
| 123 | translesion synthesis (GO:0019985) | 2.59549653 |
| 124 | response to type I interferon (GO:0034340) | 2.59334505 |
| 125 | macrophage activation involved in immune response (GO:0002281) | 2.59228091 |
| 126 | cellular component biogenesis (GO:0044085) | 2.58774825 |
| 127 | T cell homeostasis (GO:0043029) | 2.58375769 |
| 128 | regulation of superoxide anion generation (GO:0032928) | 2.57247231 |
| 129 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.57010803 |
| 130 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.56507652 |
| 131 | necroptotic process (GO:0070266) | 2.55963008 |
| 132 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.55575211 |
| 133 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.54639428 |
| 134 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.54136173 |
| 135 | deoxyribose phosphate catabolic process (GO:0046386) | 2.53607778 |
| 136 | IMP biosynthetic process (GO:0006188) | 2.53287822 |
| 137 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.53247846 |
| 138 | respiratory chain complex IV assembly (GO:0008535) | 2.53068267 |
| 139 | regulation of leukocyte degranulation (GO:0043300) | 2.52468018 |
| 140 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.52217506 |
| 141 | response to interferon-alpha (GO:0035455) | 2.49955548 |
| 142 | secretory granule organization (GO:0033363) | 2.49230791 |
| 143 | B cell mediated immunity (GO:0019724) | 2.48904570 |
| 144 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.48503740 |
| 145 | regulation of regulatory T cell differentiation (GO:0045589) | 2.48264911 |
| 146 | telomere maintenance (GO:0000723) | 2.48013211 |
| 147 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.47930456 |
| 148 | response to muramyl dipeptide (GO:0032495) | 2.47920124 |
| 149 | telomere organization (GO:0032200) | 2.47668451 |
| 150 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.47372970 |
| 151 | viral mRNA export from host cell nucleus (GO:0046784) | 2.46875308 |
| 152 | negative regulation of T cell mediated immunity (GO:0002710) | 2.46618854 |
| 153 | positive regulation of tolerance induction (GO:0002645) | 2.46165158 |
| 154 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.45801525 |
| 155 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.45571948 |
| 156 | response to host immune response (GO:0052572) | 2.45571948 |
| 157 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.45016079 |
| 158 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.44827424 |
| 159 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.43427789 |
| 160 | chromatin remodeling at centromere (GO:0031055) | 2.43345063 |
| 161 | purine nucleotide salvage (GO:0032261) | 2.42611003 |
| 162 | mast cell activation involved in immune response (GO:0002279) | 2.42597189 |
| 163 | mast cell degranulation (GO:0043303) | 2.42597189 |
| 164 | detection of biotic stimulus (GO:0009595) | 2.42437752 |
| 165 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 2.41917657 |
| 166 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.41876875 |
| 167 | T cell migration (GO:0072678) | 2.41837475 |
| 168 | proteasome assembly (GO:0043248) | 2.41022555 |
| 169 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.40996188 |
| 170 | ncRNA 3-end processing (GO:0043628) | 2.40971039 |
| 171 | NADPH regeneration (GO:0006740) | 2.40817433 |
| 172 | metallo-sulfur cluster assembly (GO:0031163) | 2.40741039 |
| 173 | iron-sulfur cluster assembly (GO:0016226) | 2.40741039 |
| 174 | regulation of protein heterodimerization activity (GO:0043497) | 2.40626820 |
| 175 | actin nucleation (GO:0045010) | 2.39743733 |
| 176 | establishment of integrated proviral latency (GO:0075713) | 2.39040391 |
| 177 | regulation of erythrocyte differentiation (GO:0045646) | 2.38345794 |
| 178 | DNA replication-independent nucleosome organization (GO:0034724) | 2.37867888 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.27884034 |
| 2 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.91401544 |
| 3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.53922528 |
| 4 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.80768799 |
| 5 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.78285061 |
| 6 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.68325430 |
| 7 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.56005691 |
| 8 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.52242080 |
| 9 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.50358079 |
| 10 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.50127577 |
| 11 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.46004467 |
| 12 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.45186916 |
| 13 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.44322409 |
| 14 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.42989461 |
| 15 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.41997573 |
| 16 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.36919998 |
| 17 | MYC_22102868_ChIP-Seq_BL_Human | 2.35815276 |
| 18 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.34195628 |
| 19 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.32603497 |
| 20 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.31810589 |
| 21 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.26698200 |
| 22 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.24464813 |
| 23 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.19903654 |
| 24 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.17686111 |
| 25 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.17112302 |
| 26 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.12544601 |
| 27 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.11914618 |
| 28 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.11521171 |
| 29 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.07503167 |
| 30 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.04197298 |
| 31 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.03724598 |
| 32 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.99084000 |
| 33 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.99070345 |
| 34 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.96624299 |
| 35 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.92201815 |
| 36 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.91717472 |
| 37 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.89086993 |
| 38 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.87365967 |
| 39 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.87013383 |
| 40 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.83408699 |
| 41 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.82159106 |
| 42 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.82070314 |
| 43 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.79742924 |
| 44 | GATA1_22025678_ChIP-Seq_K562_Human | 1.73495198 |
| 45 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.70828174 |
| 46 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.68010885 |
| 47 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.65816117 |
| 48 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.65353552 |
| 49 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.63225750 |
| 50 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.62541574 |
| 51 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.60039941 |
| 52 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.57722453 |
| 53 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.56747394 |
| 54 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.56271008 |
| 55 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.53394838 |
| 56 | SPI1_23127762_ChIP-Seq_K562_Human | 1.48173841 |
| 57 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.48042918 |
| 58 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.46531746 |
| 59 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.46469204 |
| 60 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.44949014 |
| 61 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.44318979 |
| 62 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.43350588 |
| 63 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42663425 |
| 64 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.41131512 |
| 65 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.41002959 |
| 66 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.40333662 |
| 67 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.40315082 |
| 68 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40131861 |
| 69 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.40117000 |
| 70 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.39569260 |
| 71 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.38488013 |
| 72 | * MYB_26560356_Chip-Seq_TH2_Human | 1.38066417 |
| 73 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.37179872 |
| 74 | MAF_26560356_Chip-Seq_TH1_Human | 1.37091157 |
| 75 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.37009614 |
| 76 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.36043350 |
| 77 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.35425450 |
| 78 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.34144003 |
| 79 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.34067636 |
| 80 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.33136030 |
| 81 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.31995578 |
| 82 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.31383447 |
| 83 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.30200996 |
| 84 | UTX_26944678_Chip-Seq_JUKART_Human | 1.29464114 |
| 85 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.28841705 |
| 86 | MYB_26560356_Chip-Seq_TH1_Human | 1.28798192 |
| 87 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.27422574 |
| 88 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.26576491 |
| 89 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.25215525 |
| 90 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.23577876 |
| 91 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.23071427 |
| 92 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.22326552 |
| 93 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.22161017 |
| 94 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.21593782 |
| 95 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.21136719 |
| 96 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.20749920 |
| 97 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20626924 |
| 98 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.20265807 |
| 99 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.20043302 |
| 100 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.17213171 |
| 101 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.17152891 |
| 102 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.16036457 |
| 103 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.15488788 |
| 104 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.14909701 |
| 105 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.14701958 |
| 106 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.12062241 |
| 107 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.11595737 |
| 108 | GATA3_26560356_Chip-Seq_TH2_Human | 1.10826780 |
| 109 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.10702236 |
| 110 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.09896058 |
| 111 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.09652435 |
| 112 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08806790 |
| 113 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.06687238 |
| 114 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.04380990 |
| 115 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.03809187 |
| 116 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.03529717 |
| 117 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.03460982 |
| 118 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.03409351 |
| 119 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.03260609 |
| 120 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.02861002 |
| 121 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.01854944 |
| 122 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.01804849 |
| 123 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.01699310 |
| 124 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.01459434 |
| 125 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.01145722 |
| 126 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00191644 |
| 127 | MAF_26560356_Chip-Seq_TH2_Human | 0.99577061 |
| 128 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.98958022 |
| 129 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.97842211 |
| 130 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.97037186 |
| 131 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.96510844 |
| 132 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.95959932 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002396_abnormal_hematopoietic_system | 4.50098274 |
| 2 | MP0003693_abnormal_embryo_hatching | 3.36777113 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.32692444 |
| 4 | MP0005397_hematopoietic_system_phenotyp | 2.79772240 |
| 5 | MP0001545_abnormal_hematopoietic_system | 2.79772240 |
| 6 | MP0004808_abnormal_hematopoietic_stem | 2.66548289 |
| 7 | MP0000685_abnormal_immune_system | 2.65575304 |
| 8 | MP0005174_abnormal_tail_pigmentation | 2.58131354 |
| 9 | MP0010094_abnormal_chromosome_stability | 2.55995840 |
| 10 | MP0009785_altered_susceptibility_to | 2.54922561 |
| 11 | MP0003806_abnormal_nucleotide_metabolis | 2.52690059 |
| 12 | MP0005075_abnormal_melanosome_morpholog | 2.48706999 |
| 13 | MP0000490_abnormal_crypts_of | 2.42892337 |
| 14 | MP0005671_abnormal_response_to | 2.38560643 |
| 15 | MP0004957_abnormal_blastocyst_morpholog | 2.32641391 |
| 16 | MP0002398_abnormal_bone_marrow | 2.31798753 |
| 17 | MP0000465_gastrointestinal_hemorrhage | 2.31596529 |
| 18 | MP0005464_abnormal_platelet_physiology | 2.30722598 |
| 19 | MP0003763_abnormal_thymus_physiology | 2.27822154 |
| 20 | MP0003111_abnormal_nucleus_morphology | 2.22151861 |
| 21 | MP0005025_abnormal_response_to | 2.22101063 |
| 22 | MP0003077_abnormal_cell_cycle | 2.20201946 |
| 23 | MP0008007_abnormal_cellular_replicative | 2.19230195 |
| 24 | MP0008057_abnormal_DNA_replication | 2.18172622 |
| 25 | MP0001800_abnormal_humoral_immune | 2.09672865 |
| 26 | MP0002420_abnormal_adaptive_immunity | 2.06267900 |
| 27 | MP0009333_abnormal_splenocyte_physiolog | 2.04216541 |
| 28 | MP0001819_abnormal_immune_cell | 2.02235215 |
| 29 | MP0000689_abnormal_spleen_morphology | 2.01595626 |
| 30 | MP0003436_decreased_susceptibility_to | 2.01153580 |
| 31 | MP0002166_altered_tumor_susceptibility | 1.99398995 |
| 32 | MP0002452_abnormal_antigen_presenting | 1.97843652 |
| 33 | MP0008058_abnormal_DNA_repair | 1.95896086 |
| 34 | MP0002722_abnormal_immune_system | 1.95683350 |
| 35 | MP0000716_abnormal_immune_system | 1.95507785 |
| 36 | MP0002723_abnormal_immune_serum | 1.94314211 |
| 37 | MP0002419_abnormal_innate_immunity | 1.91490497 |
| 38 | MP0009379_abnormal_foot_pigmentation | 1.91134010 |
| 39 | MP0005000_abnormal_immune_tolerance | 1.90190753 |
| 40 | MP0001853_heart_inflammation | 1.88862224 |
| 41 | MP0003724_increased_susceptibility_to | 1.87229458 |
| 42 | MP0002429_abnormal_blood_cell | 1.86585213 |
| 43 | MP0002148_abnormal_hypersensitivity_rea | 1.83450253 |
| 44 | MP0001873_stomach_inflammation | 1.79773291 |
| 45 | MP0002095_abnormal_skin_pigmentation | 1.71229936 |
| 46 | MP0009764_decreased_sensitivity_to | 1.61046793 |
| 47 | MP0003075_altered_response_to | 1.58665606 |
| 48 | MP0010155_abnormal_intestine_physiology | 1.56961443 |
| 49 | MP0000703_abnormal_thymus_morphology | 1.56857363 |
| 50 | MP0002019_abnormal_tumor_incidence | 1.55404661 |
| 51 | MP0002006_tumorigenesis | 1.54561773 |
| 52 | MP0003866_abnormal_defecation | 1.52660938 |
| 53 | MP0002277_abnormal_respiratory_mucosa | 1.52620264 |
| 54 | MP0002405_respiratory_system_inflammati | 1.49204499 |
| 55 | MP0006054_spinal_hemorrhage | 1.45165467 |
| 56 | MP0001790_abnormal_immune_system | 1.40188191 |
| 57 | MP0005387_immune_system_phenotype | 1.40188191 |
| 58 | MP0009278_abnormal_bone_marrow | 1.36377519 |
| 59 | MP0003172_abnormal_lysosome_physiology | 1.34225902 |
| 60 | MP0001845_abnormal_inflammatory_respons | 1.29534897 |
| 61 | MP0001986_abnormal_taste_sensitivity | 1.29267504 |
| 62 | MP0003303_peritoneal_inflammation | 1.29154205 |
| 63 | MP0000015_abnormal_ear_pigmentation | 1.28363968 |
| 64 | MP0005451_abnormal_body_composition | 1.27177892 |
| 65 | MP0004147_increased_porphyrin_level | 1.26468179 |
| 66 | MP0003656_abnormal_erythrocyte_physiolo | 1.21874807 |
| 67 | MP0008260_abnormal_autophagy | 1.21748103 |
| 68 | MP0000313_abnormal_cell_death | 1.21248766 |
| 69 | MP0005166_decreased_susceptibility_to | 1.16823431 |
| 70 | MP0000858_altered_metastatic_potential | 1.15389199 |
| 71 | MP0008469_abnormal_protein_level | 1.14860183 |
| 72 | MP0003186_abnormal_redox_activity | 1.14403651 |
| 73 | MP0006036_abnormal_mitochondrial_physio | 1.14242415 |
| 74 | MP0003786_premature_aging | 1.12563766 |
| 75 | MP0002138_abnormal_hepatobiliary_system | 1.11396097 |
| 76 | MP0002877_abnormal_melanocyte_morpholog | 1.10450862 |
| 77 | MP0010352_gastrointestinal_tract_polyps | 1.09080033 |
| 78 | MP0010307_abnormal_tumor_latency | 1.07607132 |
| 79 | MP0000350_abnormal_cell_proliferation | 0.99635801 |
| 80 | MP0001851_eye_inflammation | 0.98886730 |
| 81 | MP0002998_abnormal_bone_remodeling | 0.97071584 |
| 82 | MP0005390_skeleton_phenotype | 0.93482907 |
| 83 | MP0000343_altered_response_to | 0.92213195 |
| 84 | MP0008932_abnormal_embryonic_tissue | 0.91981629 |
| 85 | MP0001533_abnormal_skeleton_physiology | 0.89771099 |
| 86 | MP0005165_increased_susceptibility_to | 0.89561721 |
| 87 | MP0002132_abnormal_respiratory_system | 0.88931781 |
| 88 | MP0003448_altered_tumor_morphology | 0.86255242 |
| 89 | MP0000358_abnormal_cell_content/ | 0.86048185 |
| 90 | MP0005058_abnormal_lysosome_morphology | 0.85688497 |
| 91 | MP0001542_abnormal_bone_strength | 0.83064242 |
| 92 | MP0004947_skin_inflammation | 0.81575487 |
| 93 | MP0001663_abnormal_digestive_system | 0.81415562 |
| 94 | MP0005164_abnormal_response_to | 0.80015527 |
| 95 | MP0009840_abnormal_foam_cell | 0.78241974 |
| 96 | MP0000477_abnormal_intestine_morphology | 0.76327253 |
| 97 | MP0009765_abnormal_xenobiotic_induced | 0.75201650 |
| 98 | MP0004510_myositis | 0.74897091 |
| 99 | MP0005310_abnormal_salivary_gland | 0.74618485 |
| 100 | MP0004883_abnormal_blood_vessel | 0.74615142 |
| 101 | MP0003567_abnormal_fetal_cardiomyocyte | 0.73871417 |
| 102 | MP0003221_abnormal_cardiomyocyte_apopto | 0.73663874 |
| 103 | MP0003191_abnormal_cellular_cholesterol | 0.73296034 |
| 104 | MP0003300_gastrointestinal_ulcer | 0.72454450 |
| 105 | MP0002080_prenatal_lethality | 0.71223759 |
| 106 | MP0002933_joint_inflammation | 0.71222066 |
| 107 | MP0001730_embryonic_growth_arrest | 0.70850397 |
| 108 | MP0006292_abnormal_olfactory_placode | 0.70696457 |
| 109 | MP0003943_abnormal_hepatobiliary_system | 0.69926780 |
| 110 | MP0000249_abnormal_blood_vessel | 0.69708488 |
| 111 | MP0002075_abnormal_coat/hair_pigmentati | 0.68714143 |
| 112 | MP0005319_abnormal_enzyme/_coenzyme | 0.68294833 |
| 113 | MP0003315_abnormal_perineum_morphology | 0.67616073 |
| 114 | MP0008873_increased_physiological_sensi | 0.67465459 |
| 115 | MP0000371_diluted_coat_color | 0.67083338 |
| 116 | MP0003183_abnormal_peptide_metabolism | 0.66673165 |
| 117 | MP0003795_abnormal_bone_structure | 0.66328996 |
| 118 | MP0001764_abnormal_homeostasis | 0.65997220 |
| 119 | MP0002653_abnormal_ependyma_morphology | 0.62981501 |
| 120 | MP0009763_increased_sensitivity_to | 0.62614612 |
| 121 | MP0006035_abnormal_mitochondrial_morpho | 0.61846734 |
| 122 | MP0000598_abnormal_liver_morphology | 0.60710158 |
| 123 | MP0004381_abnormal_hair_follicle | 0.59676286 |
| 124 | MP0000604_amyloidosis | 0.58481686 |
| 125 | MP0003828_pulmonary_edema | 0.58351361 |
| 126 | MP0005409_darkened_coat_color | 0.57752753 |
| 127 | MP0002163_abnormal_gland_morphology | 0.56451741 |
| 128 | MP0001348_abnormal_lacrimal_gland | 0.56302148 |
| 129 | MP0006082_CNS_inflammation | 0.55251803 |
| 130 | MP0000681_abnormal_thyroid_gland | 0.54216810 |
| 131 | MP0004185_abnormal_adipocyte_glucose | 0.54169039 |
| 132 | MP0005084_abnormal_gallbladder_morpholo | 0.52496236 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of cells of the erythroid lineage (HP:0012130) | 5.78707480 |
| 2 | Abnormal number of erythroid precursors (HP:0012131) | 5.73351839 |
| 3 | Thrombocytosis (HP:0001894) | 5.39257640 |
| 4 | Aplastic anemia (HP:0001915) | 5.37531579 |
| 5 | Reticulocytopenia (HP:0001896) | 4.89579530 |
| 6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.41442183 |
| 7 | Chronic otitis media (HP:0000389) | 4.40657107 |
| 8 | IgM deficiency (HP:0002850) | 4.32110006 |
| 9 | Petechiae (HP:0000967) | 4.04973347 |
| 10 | Stomatitis (HP:0010280) | 4.03660932 |
| 11 | Reduced antithrombin III activity (HP:0001976) | 3.88862230 |
| 12 | Abnormality of glycolipid metabolism (HP:0010969) | 3.75579518 |
| 13 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.75579518 |
| 14 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.75579518 |
| 15 | Type I transferrin isoform profile (HP:0003642) | 3.68701928 |
| 16 | Vacuolated lymphocytes (HP:0001922) | 3.62014794 |
| 17 | Pallor (HP:0000980) | 3.56973254 |
| 18 | Myositis (HP:0100614) | 3.36820353 |
| 19 | Pustule (HP:0200039) | 3.30559793 |
| 20 | Macrocytic anemia (HP:0001972) | 3.29003088 |
| 21 | Increased IgM level (HP:0003496) | 3.20379211 |
| 22 | Prolonged bleeding time (HP:0003010) | 3.18981958 |
| 23 | Recurrent abscess formation (HP:0002722) | 3.17832660 |
| 24 | Recurrent bronchitis (HP:0002837) | 3.08856333 |
| 25 | Abnormal protein N-linked glycosylation (HP:0012347) | 3.08577120 |
| 26 | Abnormal protein glycosylation (HP:0012346) | 3.08577120 |
| 27 | Abnormal glycosylation (HP:0012345) | 3.08577120 |
| 28 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 3.08577120 |
| 29 | Abnormality of T cell physiology (HP:0011840) | 3.06221994 |
| 30 | Orchitis (HP:0100796) | 3.04144880 |
| 31 | Recurrent cutaneous fungal infections (HP:0011370) | 2.97993353 |
| 32 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.97993353 |
| 33 | Increased cerebral lipofuscin (HP:0011813) | 2.88126011 |
| 34 | T lymphocytopenia (HP:0005403) | 2.85836243 |
| 35 | Dysostosis multiplex (HP:0000943) | 2.84631369 |
| 36 | Abnormality of T cell number (HP:0011839) | 2.84425490 |
| 37 | Recurrent bacterial skin infections (HP:0005406) | 2.82482636 |
| 38 | Urticaria (HP:0001025) | 2.77324083 |
| 39 | Poikiloderma (HP:0001029) | 2.75422548 |
| 40 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.75073876 |
| 41 | Autoimmune hemolytic anemia (HP:0001890) | 2.73734797 |
| 42 | Panhypogammaglobulinemia (HP:0003139) | 2.73678739 |
| 43 | Severe combined immunodeficiency (HP:0004430) | 2.73466220 |
| 44 | Recurrent viral infections (HP:0004429) | 2.72776940 |
| 45 | Impaired platelet aggregation (HP:0003540) | 2.71621261 |
| 46 | Abnormal platelet function (HP:0011869) | 2.71621261 |
| 47 | Hepatosplenomegaly (HP:0001433) | 2.68157096 |
| 48 | Nasal polyposis (HP:0100582) | 2.67266090 |
| 49 | Pulmonary infiltrates (HP:0002113) | 2.67028575 |
| 50 | Oral leukoplakia (HP:0002745) | 2.62786177 |
| 51 | Microretrognathia (HP:0000308) | 2.61908397 |
| 52 | Acute lymphatic leukemia (HP:0006721) | 2.61844667 |
| 53 | Cellulitis (HP:0100658) | 2.61561255 |
| 54 | Muscle fiber atrophy (HP:0100295) | 2.59446489 |
| 55 | Abnormality of the nasal mucosa (HP:0000433) | 2.57502618 |
| 56 | Autoimmune thrombocytopenia (HP:0001973) | 2.57216825 |
| 57 | Epistaxis (HP:0000421) | 2.57173091 |
| 58 | Pancytopenia (HP:0001876) | 2.57054812 |
| 59 | Retrobulbar optic neuritis (HP:0100654) | 2.55914200 |
| 60 | Optic neuritis (HP:0100653) | 2.55914200 |
| 61 | Eosinophilia (HP:0001880) | 2.55693720 |
| 62 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.55430467 |
| 63 | Meningitis (HP:0001287) | 2.53625803 |
| 64 | Vasculitis (HP:0002633) | 2.48929465 |
| 65 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.47342172 |
| 66 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.47342172 |
| 67 | Amyloidosis (HP:0011034) | 2.47224917 |
| 68 | Mitochondrial inheritance (HP:0001427) | 2.46482011 |
| 69 | Type 2 muscle fiber atrophy (HP:0003554) | 2.45856455 |
| 70 | Abnormality of B cell number (HP:0010975) | 2.43055545 |
| 71 | B lymphocytopenia (HP:0010976) | 2.43055545 |
| 72 | Combined immunodeficiency (HP:0005387) | 2.41752377 |
| 73 | Loss of speech (HP:0002371) | 2.41185539 |
| 74 | Increased IgE level (HP:0003212) | 2.40856962 |
| 75 | Leukocytosis (HP:0001974) | 2.39860298 |
| 76 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.38832789 |
| 77 | Myelodysplasia (HP:0002863) | 2.38271382 |
| 78 | Encephalitis (HP:0002383) | 2.37723834 |
| 79 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.37483740 |
| 80 | Colon cancer (HP:0003003) | 2.37454263 |
| 81 | Recurrent fungal infections (HP:0002841) | 2.35106190 |
| 82 | Lymphoma (HP:0002665) | 2.32774609 |
| 83 | Abnormality of the prostate (HP:0008775) | 2.31886680 |
| 84 | 11 pairs of ribs (HP:0000878) | 2.29333457 |
| 85 | Hypertensive crisis (HP:0100735) | 2.29222225 |
| 86 | Abnormality of T cells (HP:0002843) | 2.28656551 |
| 87 | Severe visual impairment (HP:0001141) | 2.27996501 |
| 88 | Entropion (HP:0000621) | 2.27104894 |
| 89 | Gastrointestinal inflammation (HP:0004386) | 2.26596657 |
| 90 | Polygenic inheritance (HP:0010982) | 2.25994931 |
| 91 | Hepatocellular necrosis (HP:0001404) | 2.25033355 |
| 92 | Increased serum ferritin (HP:0003281) | 2.24156623 |
| 93 | Albinism (HP:0001022) | 2.21658341 |
| 94 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.20147628 |
| 95 | IgG deficiency (HP:0004315) | 2.18398000 |
| 96 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.16944299 |
| 97 | Inflammation of the large intestine (HP:0002037) | 2.16322716 |
| 98 | Interstitial pulmonary disease (HP:0006530) | 2.16126905 |
| 99 | Progressive neurologic deterioration (HP:0002344) | 2.16001523 |
| 100 | Birth length less than 3rd percentile (HP:0003561) | 2.14918746 |
| 101 | Acute myeloid leukemia (HP:0004808) | 2.14835990 |
| 102 | Abnormality of the columella (HP:0009929) | 2.13278278 |
| 103 | Hepatic necrosis (HP:0002605) | 2.12497611 |
| 104 | Abnormality of eosinophils (HP:0001879) | 2.11423303 |
| 105 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.10432110 |
| 106 | Anorexia (HP:0002039) | 2.09639104 |
| 107 | Abnormality of macrophages (HP:0004311) | 2.08682642 |
| 108 | Gastrointestinal infarctions (HP:0005244) | 2.07910204 |
| 109 | Obstructive lung disease (HP:0006536) | 2.06723570 |
| 110 | Chronic obstructive pulmonary disease (HP:0006510) | 2.06723570 |
| 111 | Acute necrotizing encephalopathy (HP:0006965) | 2.06329908 |
| 112 | Agammaglobulinemia (HP:0004432) | 2.06297241 |
| 113 | Recurrent skin infections (HP:0001581) | 2.06161190 |
| 114 | Neutropenia (HP:0001875) | 2.05569092 |
| 115 | Lymphopenia (HP:0001888) | 2.05385113 |
| 116 | Hemoptysis (HP:0002105) | 2.05331002 |
| 117 | Amaurosis fugax (HP:0100576) | 2.04905846 |
| 118 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.04390152 |
| 119 | Pulmonary fibrosis (HP:0002206) | 2.03975998 |
| 120 | Papilloma (HP:0012740) | 2.02025556 |
| 121 | Verrucae (HP:0200043) | 2.02025556 |
| 122 | Microcytic anemia (HP:0001935) | 2.01590370 |
| 123 | Increased muscle lipid content (HP:0009058) | 2.00737711 |
| 124 | Increased CSF lactate (HP:0002490) | 1.99242833 |
| 125 | Hypoplasia of the thymus (HP:0000778) | 1.98149918 |
| 126 | Episodic fever (HP:0001954) | 1.98019422 |
| 127 | Skin rash (HP:0000988) | 1.97495187 |
| 128 | Abnormality of iron homeostasis (HP:0011031) | 1.96163997 |
| 129 | Mediastinal lymphadenopathy (HP:0100721) | 1.96058920 |
| 130 | Chronic sinusitis (HP:0011109) | 1.95649095 |
| 131 | Exertional dyspnea (HP:0002875) | 1.94673133 |
| 132 | Broad face (HP:0000283) | 1.94158294 |
| 133 | Agnosia (HP:0010524) | 1.94007157 |
| 134 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.93588700 |
| 135 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.93588700 |
| 136 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.93588700 |
| 137 | Fatigue (HP:0012378) | 1.93456141 |
| 138 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.93106937 |
| 139 | Poor head control (HP:0002421) | 1.92695622 |
| 140 | Bone marrow hypocellularity (HP:0005528) | 1.92590783 |
| 141 | Sepsis (HP:0100806) | 1.92434639 |
| 142 | Eczematoid dermatitis (HP:0000976) | 1.92279263 |
| 143 | Erythema (HP:0010783) | 1.91471373 |
| 144 | Abnormality of DNA repair (HP:0003254) | 1.91350536 |
| 145 | Keratoconjunctivitis sicca (HP:0001097) | 1.90972687 |
| 146 | Skin ulcer (HP:0200042) | 1.90209727 |
| 147 | Granulocytopenia (HP:0001913) | 1.88916041 |
| 148 | Thoracic kyphosis (HP:0002942) | 1.88897749 |
| 149 | Progressive muscle weakness (HP:0003323) | 1.88381914 |
| 150 | Chest pain (HP:0100749) | 1.87519551 |
| 151 | Abnormality of the thoracic spine (HP:0100711) | 1.82521140 |
| 152 | Increased intramyocellular lipid droplets (HP:0012240) | 1.80992328 |
| 153 | 3-Methylglutaconic aciduria (HP:0003535) | 1.80157528 |
| 154 | Hypergammaglobulinemia (HP:0010702) | 1.75208758 |
| 155 | Hypoproteinemia (HP:0003075) | 1.74973070 |
| 156 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.74905249 |
| 157 | Purpura (HP:0000979) | 1.74859970 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK16 | 3.81713710 |
| 2 | KIT | 3.05419079 |
| 3 | WEE1 | 3.01043255 |
| 4 | NME2 | 2.89840593 |
| 5 | VRK2 | 2.76397548 |
| 6 | FLT3 | 2.76366168 |
| 7 | EEF2K | 2.74880698 |
| 8 | PIM2 | 2.56247691 |
| 9 | MAP4K1 | 2.52758689 |
| 10 | BUB1 | 2.31564085 |
| 11 | SCYL2 | 2.22324818 |
| 12 | TEC | 2.19087197 |
| 13 | BTK | 2.10928690 |
| 14 | CDK19 | 2.10655373 |
| 15 | TNIK | 2.03746309 |
| 16 | EIF2AK3 | 1.98552937 |
| 17 | ACVR1B | 1.97359138 |
| 18 | RPS6KB2 | 1.89529393 |
| 19 | CSK | 1.86350374 |
| 20 | CSF1R | 1.82443794 |
| 21 | TESK1 | 1.74767218 |
| 22 | VRK1 | 1.71614561 |
| 23 | MAP3K3 | 1.69579335 |
| 24 | MAP2K3 | 1.62691884 |
| 25 | CDC7 | 1.60493247 |
| 26 | TGFBR1 | 1.54493026 |
| 27 | DYRK3 | 1.52255175 |
| 28 | NEK2 | 1.50463763 |
| 29 | MAPKAPK3 | 1.45218377 |
| 30 | IRAK4 | 1.43001613 |
| 31 | KDR | 1.42641552 |
| 32 | BRSK2 | 1.42113994 |
| 33 | MAP3K12 | 1.41186623 |
| 34 | BLK | 1.39483522 |
| 35 | MAP3K14 | 1.36070694 |
| 36 | IRAK3 | 1.31814528 |
| 37 | MAP3K13 | 1.30244086 |
| 38 | EIF2AK1 | 1.29583570 |
| 39 | FES | 1.28944479 |
| 40 | SYK | 1.28863915 |
| 41 | TAOK2 | 1.28731453 |
| 42 | TESK2 | 1.27767434 |
| 43 | LRRK2 | 1.27594892 |
| 44 | ARAF | 1.27220949 |
| 45 | PKN2 | 1.26741469 |
| 46 | TBK1 | 1.25501434 |
| 47 | ZAP70 | 1.23821767 |
| 48 | MATK | 1.19465088 |
| 49 | EPHA2 | 1.19387058 |
| 50 | ABL2 | 1.16659775 |
| 51 | CDK7 | 1.15034850 |
| 52 | BMPR2 | 1.10399883 |
| 53 | JAK3 | 1.05405419 |
| 54 | GRK7 | 1.03224310 |
| 55 | BCKDK | 1.02664856 |
| 56 | CAMKK2 | 1.02418428 |
| 57 | CCNB1 | 1.00571999 |
| 58 | RPS6KA4 | 0.99288759 |
| 59 | PIM1 | 0.97823832 |
| 60 | MST4 | 0.97322648 |
| 61 | MUSK | 0.96794709 |
| 62 | CDK4 | 0.95441738 |
| 63 | TYK2 | 0.95099727 |
| 64 | ATR | 0.95061407 |
| 65 | EPHB1 | 0.94184761 |
| 66 | MAP3K11 | 0.94031718 |
| 67 | PAK4 | 0.93376376 |
| 68 | NLK | 0.92769329 |
| 69 | ERN1 | 0.92190511 |
| 70 | RAF1 | 0.89658249 |
| 71 | MAPKAPK5 | 0.89006503 |
| 72 | PASK | 0.88719013 |
| 73 | SRPK1 | 0.88652158 |
| 74 | MKNK1 | 0.87285774 |
| 75 | GRK6 | 0.86350808 |
| 76 | MAP3K10 | 0.84558788 |
| 77 | LYN | 0.84494321 |
| 78 | LMTK2 | 0.84094904 |
| 79 | MOS | 0.83699064 |
| 80 | TGFBR2 | 0.80851793 |
| 81 | IKBKE | 0.80646847 |
| 82 | TAOK1 | 0.80199274 |
| 83 | TSSK6 | 0.79378324 |
| 84 | TLK1 | 0.78486674 |
| 85 | PRPF4B | 0.76468586 |
| 86 | DAPK1 | 0.74506980 |
| 87 | LIMK1 | 0.74241924 |
| 88 | CDK8 | 0.73354298 |
| 89 | FGR | 0.70710377 |
| 90 | HIPK2 | 0.69569106 |
| 91 | LCK | 0.69142710 |
| 92 | TAOK3 | 0.68743709 |
| 93 | AURKB | 0.67938744 |
| 94 | ILK | 0.67051728 |
| 95 | BRSK1 | 0.66561203 |
| 96 | IKBKB | 0.65972984 |
| 97 | STK10 | 0.65457586 |
| 98 | MARK3 | 0.64432487 |
| 99 | PRKD2 | 0.64122173 |
| 100 | MAP3K1 | 0.64100685 |
| 101 | MAPK4 | 0.64058204 |
| 102 | PRKCI | 0.63108423 |
| 103 | MAP3K6 | 0.61370638 |
| 104 | TXK | 0.59696559 |
| 105 | MAP3K8 | 0.58259895 |
| 106 | TRIB3 | 0.58007375 |
| 107 | PLK1 | 0.53978672 |
| 108 | CLK1 | 0.53116647 |
| 109 | PTK2B | 0.52852583 |
| 110 | PRKCQ | 0.52388395 |
| 111 | MAPK11 | 0.51263020 |
| 112 | MAPKAPK2 | 0.50650017 |
| 113 | HCK | 0.49624157 |
| 114 | MKNK2 | 0.48464828 |
| 115 | ADRBK2 | 0.47885692 |
| 116 | PRKG2 | 0.47851011 |
| 117 | ITK | 0.47630205 |
| 118 | CAMK1 | 0.47370772 |
| 119 | STK4 | 0.46852489 |
| 120 | EIF2AK2 | 0.45989732 |
| 121 | RPS6KA6 | 0.44514554 |
| 122 | TNK2 | 0.43649726 |
| 123 | MYLK | 0.43202255 |
| 124 | JAK2 | 0.41974204 |
| 125 | IRAK1 | 0.41231447 |
| 126 | RIPK4 | 0.38761734 |
| 127 | RPS6KC1 | 0.38713712 |
| 128 | RPS6KL1 | 0.38713712 |
| 129 | JAK1 | 0.38640192 |
| 130 | PAK1 | 0.38607587 |
| 131 | BMPR1B | 0.37087271 |
| 132 | SMG1 | 0.36096356 |
| 133 | CSNK2A2 | 0.35307656 |
| 134 | PLK4 | 0.35240896 |
| 135 | CSNK2A1 | 0.33485185 |
| 136 | ADRBK1 | 0.33441595 |
| 137 | BRAF | 0.28538332 |
| 138 | PDK1 | 0.28458699 |
| 139 | CHUK | 0.27692590 |
| 140 | MST1R | 0.26867312 |
| 141 | PTK6 | 0.26629852 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 5.15847381 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 4.93006580 |
| 3 | Mismatch repair_Homo sapiens_hsa03430 | 3.63204736 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.06547120 |
| 5 | Base excision repair_Homo sapiens_hsa03410 | 2.98325829 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.90579833 |
| 7 | Homologous recombination_Homo sapiens_hsa03440 | 2.68540602 |
| 8 | Proteasome_Homo sapiens_hsa03050 | 2.59575166 |
| 9 | Spliceosome_Homo sapiens_hsa03040 | 2.43998938 |
| 10 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.35658259 |
| 11 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.34925620 |
| 12 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.30698149 |
| 13 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.28297122 |
| 14 | RNA polymerase_Homo sapiens_hsa03020 | 2.22621550 |
| 15 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.07210077 |
| 16 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.02915920 |
| 17 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.97986513 |
| 18 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.77878501 |
| 19 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.74278018 |
| 20 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.73399023 |
| 21 | Viral myocarditis_Homo sapiens_hsa05416 | 1.71254352 |
| 22 | Cell cycle_Homo sapiens_hsa04110 | 1.70362678 |
| 23 | RNA transport_Homo sapiens_hsa03013 | 1.62880396 |
| 24 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.59465157 |
| 25 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.57505736 |
| 26 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.51199326 |
| 27 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.50839919 |
| 28 | Lysosome_Homo sapiens_hsa04142 | 1.44658734 |
| 29 | Sulfur relay system_Homo sapiens_hsa04122 | 1.44288100 |
| 30 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.42508648 |
| 31 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.41108251 |
| 32 | RNA degradation_Homo sapiens_hsa03018 | 1.39064276 |
| 33 | Protein export_Homo sapiens_hsa03060 | 1.38489277 |
| 34 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.32869395 |
| 35 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.31498452 |
| 36 | Parkinsons disease_Homo sapiens_hsa05012 | 1.27971770 |
| 37 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.23550201 |
| 38 | Other glycan degradation_Homo sapiens_hsa00511 | 1.22281054 |
| 39 | Purine metabolism_Homo sapiens_hsa00230 | 1.19022044 |
| 40 | Leishmaniasis_Homo sapiens_hsa05140 | 1.17514716 |
| 41 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.15134279 |
| 42 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.15087721 |
| 43 | Phagosome_Homo sapiens_hsa04145 | 1.14837235 |
| 44 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.14136686 |
| 45 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.09652151 |
| 46 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.08354303 |
| 47 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.07135409 |
| 48 | Measles_Homo sapiens_hsa05162 | 1.06146566 |
| 49 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.96013732 |
| 50 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.95861233 |
| 51 | Legionellosis_Homo sapiens_hsa05134 | 0.95505793 |
| 52 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.95346631 |
| 53 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.94486284 |
| 54 | Shigellosis_Homo sapiens_hsa05131 | 0.91877652 |
| 55 | Basal transcription factors_Homo sapiens_hsa03022 | 0.91000704 |
| 56 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.90715744 |
| 57 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.88558675 |
| 58 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.87993807 |
| 59 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.86564086 |
| 60 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.84542186 |
| 61 | Huntingtons disease_Homo sapiens_hsa05016 | 0.84302972 |
| 62 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.83627207 |
| 63 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.82966962 |
| 64 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.81241031 |
| 65 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.80893712 |
| 66 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.78506307 |
| 67 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.78402135 |
| 68 | Thyroid cancer_Homo sapiens_hsa05216 | 0.78320024 |
| 69 | Alzheimers disease_Homo sapiens_hsa05010 | 0.77648818 |
| 70 | Asthma_Homo sapiens_hsa05310 | 0.75953096 |
| 71 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.75787881 |
| 72 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.75152127 |
| 73 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.73983176 |
| 74 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.73777797 |
| 75 | Galactose metabolism_Homo sapiens_hsa00052 | 0.72000537 |
| 76 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.70212781 |
| 77 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.69496261 |
| 78 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.68824699 |
| 79 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.67415922 |
| 80 | Hepatitis B_Homo sapiens_hsa05161 | 0.66867364 |
| 81 | Apoptosis_Homo sapiens_hsa04210 | 0.65832863 |
| 82 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.65015125 |
| 83 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.64318596 |
| 84 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.64108631 |
| 85 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.63473389 |
| 86 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.61958914 |
| 87 | Pertussis_Homo sapiens_hsa05133 | 0.61601531 |
| 88 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.61542454 |
| 89 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.61033526 |
| 90 | Influenza A_Homo sapiens_hsa05164 | 0.60083933 |
| 91 | Platelet activation_Homo sapiens_hsa04611 | 0.59995151 |
| 92 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.59334781 |
| 93 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.59162764 |
| 94 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.58649388 |
| 95 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.56403110 |
| 96 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.56092019 |
| 97 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.51476380 |
| 98 | Hepatitis C_Homo sapiens_hsa05160 | 0.51348531 |
| 99 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.50340007 |
| 100 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.48949273 |
| 101 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.48430843 |
| 102 | HTLV-I infection_Homo sapiens_hsa05166 | 0.48345243 |
| 103 | Allograft rejection_Homo sapiens_hsa05330 | 0.44816269 |
| 104 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.44603769 |
| 105 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.43619434 |
| 106 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.43470684 |
| 107 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.43446624 |
| 108 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.41409352 |
| 109 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.41374187 |
| 110 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.40897639 |
| 111 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.40710295 |
| 112 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.39317705 |
| 113 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.38095296 |
| 114 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.38012336 |
| 115 | Endocytosis_Homo sapiens_hsa04144 | 0.37515168 |
| 116 | Salmonella infection_Homo sapiens_hsa05132 | 0.36443809 |
| 117 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.36058842 |
| 118 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.35965589 |
| 119 | Malaria_Homo sapiens_hsa05144 | 0.35802757 |
| 120 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.35751981 |
| 121 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.35549792 |
| 122 | Tuberculosis_Homo sapiens_hsa05152 | 0.35237008 |
| 123 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.35228098 |
| 124 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.34780818 |
| 125 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.34120985 |
| 126 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.33673640 |
| 127 | Carbon metabolism_Homo sapiens_hsa01200 | 0.29108385 |
| 128 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.27498374 |
| 129 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.23006904 |

